Skip to main content
. 2021 May 31;113(11):1495–1505. doi: 10.1093/jnci/djab100

Table 2.

Demographic and clinical characteristics of study sample (N = 196) overall and by randomization factor

Demographic and clinical characteristics Total sample Sample characteristics by each randomization factora
Relaxation
Worry practice
Cognitive restructuring
Telecoaching
Yes No Yes No Yes No Yes No
Sample size, No. 196 98 98 98 98 98 98 97 99
Demographics
 Mean age at screening (SD), y 54.7 (9.8) 54.6 (9.3) 54.8 (10.2) 55.0 (9.4) 54.4 (10.2) 53.7 (10.0) 55.6 (9.5) 54.1 (10.1) 55.3 (9.4)
  Range 26.0-76.0 30.0-74.0 26.0-76.0 30.0-76.0 26.0-74.0 26.0-74.0 30.0-76.0 26.0-76.0 33.0-76.0
 Race, No. (%)
  Non-Hispanic White 174 (88.8) 90 (91.8) 84 (85.7) 87 (87.9) 87 (89.7) 84 (85.7) 90 (91.8) 89 (91.8) 85 (85.9)
  Hispanic White 9 (4.6) 4 (4.1) 5 (5.1) 6 (6.1) 3 (3.1) 6 (6.1) 3 (3.1) 4 (4.1) 5 (5.1)
  Non-Hispanic African American 6 (3.1) 1 (1.0) 5 (5.1) 3 (3.0) 3 (3.1) 2 (2.0) 4 (4.1) 3 (3.1) 3 (3.0)
  Non-Hispanic Asian 4 (2.0) 2 (2.0) 2 (2.0) 1 (1.0) 3 (3.1) 4 (4.1) 0 (0.0) 1 (1.0) 3 (3.0)
  Other 1 (0.5) 1 (1.0) 0 (0.0) 1 (1.0) 0 (0.0) 1 (1.0) 0 (0.0) 0 (0.0) 1 (1.0)
  Missing 2 (1.0) 0 (0.0) 2 (2.0) 1 (1.0) 1 (1.0) 1 (1.0) 1 (1.0) 0 (0.0) 2 (2.0)
 Latinx, No. (%)
  No 184 (93.9) 93 (94.9) 91 (92.9) 91 (91.9) 93 (95.9) 90 (91.8) 94 (95.9) 93 (95.9) 91 (91.9)
  Yes 11 (5.6) 4 (4.1) 7 (7.1) 7 (7.1) 4 (4.1) 7 (7.1) 4 (4.1) 4 (4.1) 7 (7.1)
  Missing 1 (0.5) 1 (1.0) 0 (0.0) 1 (1.0) 0 (0.0) 1 (1.0) 0 (0.0) 0 (0.0) 1 (1.0)
 Education, No. (%)
  Some high school 1 (0.5) 1 (1.0) 0 (0.0) 1 (1.0) 0 (0.0) 1 (1.0) 0 (0.0) 1 (1.0) 0 (0.0)
  High school graduate 7 (3.6) 4 (4.1) 3 (3.1) 4 (4.0) 3 (3.1) 2 (2.0) 5 (5.1) 2 (2.1) 5 (5.1)
  Vocational or technical school 15 (7.7) 4 (4.1) 11 (11.2) 6 (6.1) 9 (9.3) 3 (3.1) 12 (12.2) 6 (6.2) 9 (9.1)
  Some college/associate’s 40 (20.4) 15 (15.3) 25 (25.5) 21 (21.2) 19 (19.6) 23 (23.5) 17 (17.4) 25 (25.8) 15 (15.2)
  College graduate 71 (36.2) 35 (35.7) 36 (36.7) 34 (34.3) 37 (38.1) 41 (41.8) 30 (30.6) 26 (26.8) 45 (45.5)
  Graduate or professional school 53 (27.0) 33 (33.7) 20 (20.4) 27 (27.3) 26 (26.8) 24 (24.5) 29 (29.6) 33 (34.0) 20 (20.2)
  Other 2 (1.0) 2 (2.0) 0 (0.0) 2 (2.0) 0 (0.0) 0 (0.0) 2 (2.0) 1 (1.0) 1 (1.0)
  Missing 7 (3.6) 4 (4.1) 3 (3.1) 4 (4.0) 3 (3.1) 4 (4.1) 3 (3.1) 3 (3.1) 4 (4.0)
 Marital status, No. (%)
  Single 19 (9.7) 13 (13.3) 6 (6.1) 9 (9.1) 10 (10.3) 8 (8.2) 11 (11.2) 15 (15.5) 4 (4.0)
  Married/domestic partnership 153 (78.1) 73 (74.5) 80 (81.6) 76 (76.8) 77 (79.4) 77 (78.6) 76 (77.6) 73 (75.3) 80 (80.8)
  Divorced 17 (8.7) 9 (9.2) 8 (8.2) 10 (10.1) 7 (7.2) 6 (6.1) 11 (11.2) 7 (7.2) 10 (10.1)
  Separated 2 (1.0) 1 (1.0) 1 (1.0) 1 (1.0) 1 (1.0) 2 (2.0) 0 (0.0) 0 (0.0) 2 (2.0)
  Widowed 5 (2.6) 2 (2.0) 3 (3.1) 3 (3.0) 2 (2.1) 5 (5.1) 0 (0.0) 2 (2.1) 3 (3.0)
 Employment status, No. (%)
  Employed ≥32 h/wk 123 (62.8) 61 (62.2) 62 (63.3) 58 (58.6) 65 (67.0) 60 (61.2) 63 (64.3) 68 (70.1) 55 (55.6)
  Unemployed 6 (3.1) 1 (1.0) 5 (5.1) 3 (3.0) 3 (3.1) 3 (3.1) 3 (3.1) 3 (3.1) 3 (3.0)
  Homemaker 18 (9.2) 11 (11.2) 7 (7.1) 9 (9.1) 9 (9.3) 11 (11.2) 7 (7.1) 5 (5.2) 13 (13.1)
  Retired 34 (17.4) 18 (18.4) 16 (16.3) 18 (18.2) 16 (16.5) 18 (18.4) 16 (16.3) 15 (15.5) 19 (19.2)
  Disabled/medical leave 5 (2.6) 3 (3.1) 2 (2.0) 4 (4.0) 1 (1.0) 1 (1.0) 4 (4.1) 0 (0.0) 5 (5.1)
  Student 3 (1.5) 1 (1.0) 2 (2.0) 2 (2.0) 1 (1.0) 1 (1.0) 2 (2.0) 3 (3.1) 0 (0.0)
  Other 2 (1.0) 1 (1.0) 1 (1.0) 2 (2.0) 0 (0.0) 1 (1.0) 1 (1.0) 2 (2.1) 0 (0.0)
  Missing 5 (2.6) 2 (2.0) 3 (3.1) 3 (3.0) 2 (2.1) 3 (3.1) 2 (2.0) 1 (1.0) 4 (4.0)
Diagnostic history
 Stage at diagnosis, No. (%)
  Stage 0 5 (2.6) 1 (1.0) 4 (4.1) 5 (5.1) 0 (0.0) 2 (2.0) 3 (3.1) 2 (2.1) 3 (3.0)
  Stage I 87 (44.4) 48 (49.0) 39 (39.8) 40 (40.4) 47 (48.5) 42 (42.9) 45 (45.9) 47 (48.5) 40 (40.4)
  Stage II 78 (39.8) 35 (35.7) 43 (43.9) 42 (42.4) 36 (37.1) 42 (42.9) 36 (36.7) 39 (40.2) 39 (39.4)
  Stage III 26 (13.3) 14 (14.3) 12 (12.2) 12 (12.1) 14 (14.4) 12 (12.2) 14 (14.3) 9 (9.3) 17 (17.2)
 Mean age at diagnosis (SD), y 51.8 (9.4) 51.7 (8.8) 51.8 (9.9) 52.1 (8.9) 51.4 (9.8) 50.5 (9.3) 53.0 (9.2) 51.0 (9.8) 52.5 (8.9)
  Range 24.8-73.6 28.6-68.6 24.8-73.6 28.6-73.6 24.8-68.9 24.8-68.9 28.6-73.6 24.8-73.6 30.6-71.3
 Mean time since diagnosis (SD), y 3.5 (3.0) 3.4 (3.1) 3.6 (2.9) 3.4 (2.8) 3.5 (3.2) 3.7 (3.4) 3.2 (2.5) 3.6 (3.2) 3.3 (2.7)
  Range 0.2-19.1 0.3-19.1 0.2-16.9 0.2-15.2 0.4-19.1 0.2-19.1 0.4-15.2 0.4-19.1 0.2-15.2
Treatment history
 Mean time since treatment (SD), y 2.8 (2.5) 2.6 (2.4) 3.0 (2.6) 3.0 (2.8) 2.6 (2.0) 2.9 (2.4) 2.7 (2.6) 2.7 (2.1) 2.9 (2.8)
  Range 0.1-15.0 0.1-15.0 0.1-13.3 0.1-15.0 0.1-12.0 0.1-13.3 0.1-15.0 0.1-13.3 0.1-15.0
 Treatment received, No. (%)
  Surgery only 21 (10.7) 8 (8.2) 13 (13.3) 11 (11.1) 10 (10.3) 13 (13.3) 8 (8.2) 8 (8.3) 13 (13.1)
  Chemotherapy only 1 (0.5) 0 (0.0) 1 (1.0) 1 (1.0) 0 (0.0) 0 (0.0) 1 (1.0) 0 (0.0) 1 (1.0)
  Surgery + chemotherapy 37 (18.9) 20 (20.4) 17 (17.4) 21 (21.2) 16 (16.5) 18 (18.4) 19 (19.4) 18 (18.6) 19 (19.2)
  Surgery + RT 37 (18.9) 20 (20.4) 17 (17.4) 19 (19.2) 18 (18.6) 14 (14.3) 23 (23.5) 21 (21.7) 16 (16.2)
  Surgery + chemotherapy + RT 99 (50.5) 50 (51.0) 49 (50.0) 46 (46.5) 53 (54.6) 53 (54.1) 46 (46.9) 49 (50.5) 50 (50.5)
  Missing 1 (0.5) 0 (0.0) 1 (1.0) 1 (1.0) 0 (0.0) 0 (0.0) 1 (1.0) 1 (1.0) 0 (0.0)
 Targeted therapy, No. (%)
  None 148 (75.5) 77 (78.6) 71 (72.5) 76 (76.8) 72 (74.2) 77 (78.6) 71 (72.5) 76 (78.4) 72 (72.7)
  Received 43 (21.9) 17 (17.4) 26 (26.5) 22 (22.2) 21 (21.7) 18 (18.4) 25 (25.5) 19 (19.6) 24 (24.2)
  Missing 5 (2.6) 4 (4.1) 1 (1.0) 1 (1.0) 4 (4.1) 3 (3.1) 2 (2.0) 2 (2.1) 3 (3.0)
 Hormonal therapy, No. (%)
  No 38 (19.4) 14 (14.3) 24 (24.5) 21 (21.2) 17 (17.5) 22 (22.5) 16 (16.3) 17 (17.5) 21 (21.2)
  Current 137 (69.9) 73 (74.5) 64 (65.3) 66 (66.7) 71 (73.2) 70 (71.4) 67 (68.4) 65 (67.0) 72 (72.7)
  Past 20 (10.2) 10 (10.2) 10 (10.2) 12 (12.1) 8 (8.3) 6 (6.1) 14 (14.3) 14 (14.4) 6 (6.1)
  Missing 1 (0.5) 1 (1.0) 0 (0.0) 0 (0.0) 1 (1.0) 0 (0.0) 1 (1.0) 1 (1.0) 0 (0.0)
a

Participants were randomly assigned independently to each factor. Data were provided for full sample and separately by factor to demonstrate balanced randomization regarding demographics, clinical characteristics, and FoR at baseline. Sample size for each factor totaled 196; therefore, sample size summed across rows exceed 196. RT = radiation therapy.